中国生物制药(01177.HK) 上周五(10日)于联交所回购700万股,每股回购价介乎2.85至2.92元,涉资2,012.43万元。自购回授权决议案通过(2024年6月5日)至今,公司累计购回1,300万股,占已发行股份总数0.069%。(ha/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-13 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.